Impact of Acute Leg Cycling at Different Intensities on Restless Legs Syndrome Severity in Persons With Multiple Sclerosis

WithdrawnNot a drug-phase studyMS (type not specified)NCT03849001

What it found

Stopped

The trial ended early for another reason (see below).

Reason given: Study halted prematurely, prior to enrollment of first participant

What was tested

Treatment tested

  • Exercise Conditions

What it measured

Main measures

  • Restless Legs Syndrome Severity as measured by the Suggested Immobilization Test (SIT)

    10 minutes pre-exercise condition

    Physical functionBladder, bowel and sexual function
  • Restless Legs Syndrome Severity as measured by the Suggested Immobilization Test (SIT)

    10 minutes post-exercise condition

    Physical functionBladder, bowel and sexual function
  • Restless Legs Syndrome Severity as measured by the Suggested Immobilization Test (SIT)

    10 minutes pre-rest (Control) condition

    Bladder, bowel and sexual function
  • Restless Legs Syndrome Severity as measured by the Suggested Immobilization Test (SIT)

    10 minutes post-rest (Control) condition

    Bladder, bowel and sexual function

Other measures (6)

  • Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale (IRLS)

    Baseline through screening

  • Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale (IRLS)

    Baseline through week 1

  • Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale (IRLS)

    week 1 through week 2

  • Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale (IRLS)

    week 2 through week 3

  • Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale (IRLS)

    week 3 through week 4

  • Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale (IRLS)

    week 4 through week 5

Who could take part

MS (type not specified) · 18 to 54

Show the full criteria

Inclusion criteria

* 18-54 years of age * Diagnosis of multiple sclerosis * Has not experienced a relapse in the last 30 days * Positive screening for restless legs syndrome * Restless legs syndrome severity of moderate or greater * Ambulatory with or without an aide

Exclusion criteria

* Moderate or high risk for undertaking strenuous or maximal exercise * Diagnosis of: radiculopathy, peripheral edema, peripheral neuropathy, iron deficiency (i.e., anemia), renal disease, or diabetes

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this study is to evaluate the impact of acute leg cycling conditions at three different intensities versus a control condition condition on symptoms of restless legs syndrome (RLS) in persons with multiple sclerosis (MS). This study includes a proposed sample of 24 participants diagnosed with both MS and RLS that will complete four sessions of supervised exercise or rest conditions in the lab, one session per week, over the course of four weeks.

Loading reviews and guidelines…

History

    1. Started

      Sept 2019

    2. Main results due

      Sept 2019

    3. Finished

      Sept 2019

    Assembled by software from public sources.